Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study
2011

Parathyroid Hormone and Metabolic Syndrome in Obese Patients

Sample size: 1017 publication 10 minutes Evidence: moderate

Author Information

Author(s): Røislien Jo, Van Calster Ben, Hjelmesæth Jøran

Primary Institution: Morbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway

Hypothesis

Is parathyroid hormone a mediator between metabolic syndrome and various biomarkers in morbidly obese patients?

Conclusion

The study suggests that parathyroid hormone is a plausible mediator in the association between metabolic syndrome and several biomarkers, particularly in women.

Supporting Evidence

  • 68% of the patients had metabolic syndrome.
  • PTH and phosphate had significant direct effects on metabolic syndrome.
  • The study found significant gender differences in the effects of PTH on metabolic syndrome.

Takeaway

This study looked at very overweight people and found that a hormone called parathyroid hormone might help explain why they have a higher chance of having metabolic syndrome, especially in women.

Methodology

Fasting serum levels of parathyroid hormone, vitamin D, and magnesium were assessed in a cross-sectional study using Bayesian path analysis.

Potential Biases

Potential selection bias due to referral of patients to a tertiary care center.

Limitations

The cross-sectional design limits the ability to establish cause-effect relationships.

Participant Demographics

The study included 1,017 morbidly obese Caucasian individuals, with 68% being women.

Statistical Information

P-Value

0.013

Confidence Interval

95% Credibility Interval [0.15, 0.57]

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1475-2840-10-17

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication